Endpoints News

Five burning Qs for Isomorphic Labs after $2.1B raise for AI biotech
Isomorphic Labs在获得21亿美元AI生物科技B轮融资后面临的五个紧迫问题

Isomorphic Labs said Tuesday it had closed a $2.1 billion Series B round, cementing its bellwether role in using AI for drug discovery.
Isomorphic Labs周二表示,公司已完成21亿美元的B轮融资,进一步巩固其在利用AI进行药物发现领域的风向标地位。

本报道最初发表于Endpoints News。请点击这里查看原文

Isomorphic Labs said Tuesday it had closed a $2.1 billion Series B round, cementing its bellwether role in using AI for drug discovery.

Isomorphic Labs周二表示,公司已完成21亿美元的B轮融资(Series B),巩固了其在利用AI进行药物发现领域的风向标地位。

您已阅读2%(237字),剩余98%(9698字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×